Arkolith/Insider Trading/ELEV/Form 4

Ferra Joseph J Jr

CHIEF EXECUTIVE OFFICER, DirectorElevation Oncology, Inc. (ELEV) · full profile →Form 4 · filed Feb 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 15, 2025Option exercise(M)25K——134K
Feb 15, 2025Tax withholding(F)9K$0.67$6K125K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2025Grant(A)800K—$0800K
Feb 15, 2025Option exercise(M)25K—$075K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-004589) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML